UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

The Lancet (British edition), 2021-03, Vol.397 (10279), p.1057-1058

2021

Link zum Volltext

Verfügbarkeit prüfen

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

The Lancet (British edition), 2020-05, Vol.395 (10237), p.1608-1610

2020

Link zum Volltext

Verfügbarkeit prüfen

Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study

The Journal of infectious diseases, 2022-11, Vol.226 (11), p.1903-1908

2022

Link zum Volltext

Verfügbarkeit prüfen

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

Journal of Virology, 2008-12, Vol.82 (24), p.12069-12081

2008

Link zum Volltext

Verfügbarkeit prüfen

A whole genome screen for HIV restriction factors

Retrovirology, 2011-11, Vol.8 (1), p.94-94, Article 94

2011

Link zum Volltext

Verfügbarkeit prüfen

Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication

PloS one, 2010-10, Vol.5 (10), p.e13521-e13521

2010

Link zum Volltext

Verfügbarkeit prüfen

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

Nature communications, 2023-08, Vol.14 (1), p.5139-5139, Article 5139

2023

Link zum Volltext

Verfügbarkeit prüfen

RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction

Journal of virology, 2017-05, Vol.91 (10)

2017

Link zum Volltext

Verfügbarkeit prüfen

The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes

Journal of Virology, 2005-08, Vol.79 (15), p.9618-9624

2005

Link zum Volltext

Verfügbarkeit prüfen

The evolution of structured illumination microscopy in studies of HIV

Methods (San Diego, Calif.), 2015-10, Vol.88, p.20-27

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 receptors and cell tropism

British medical bulletin, 2001-09, Vol.58 (1), p.43-59

2001

Link zum Volltext

Verfügbarkeit prüfen

Curbside particulate matter and susceptibility to SARS–CoV-2 infection

The journal of allergy and clinical immunology. Global, 2023-11, Vol.2 (4), p.100141-100141, Article 100141

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection

Journal of Virology, 2005-03, Vol.79 (5), p.2823-2830

2005

Link zum Volltext

Verfügbarkeit prüfen

The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV

mBio, 2023-10, Vol.14 (6), p.e0257221-e0257221

2023

Link zum Volltext

Verfügbarkeit prüfen

Lv2, a Novel Postentry Restriction, Is Mediated by both Capsid and Envelope

Journal of Virology, 2004-02, Vol.78 (4), p.2006-2016

2004

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation

Blood, 2005-06, Vol.105 (12), p.4693-4699

2005

Link zum Volltext

Verfügbarkeit prüfen

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

Science (American Association for the Advancement of Science), 2022-01, Vol.375 (6577), p.183-192

2022

Link zum Volltext

Verfügbarkeit prüfen

An Envelope-Determined, pH-Independent Endocytic Route of Viral Entry Determines the Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 to Lv2 Restriction

Journal of Virology, 2005-08, Vol.79 (15), p.9410-9418

2005

Link zum Volltext

Verfügbarkeit prüfen

CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages

Journal of Virology, 1998-10, Vol.72 (10), p.8453-8457

1998

Link zum Volltext

Verfügbarkeit prüfen

Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease

Clinical infectious diseases, 2022-11, Vol.75 (11), p.2016-2018

2022

Link zum Volltext

Verfügbarkeit prüfen

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial

Nutrients, 2022-09, Vol.14 (18), p.3821

2022

Link zum Volltext

Verfügbarkeit prüfen

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates Infect CD4-Negative Cells via CCR5 and CXCR4: Comparison with HIV-1 and Simian Immunodeficiency Virus and Relevance to Cell Tropism In Vivo

Journal of Virology, 1999-09, Vol.73 (9), p.7795-7804

1999

Link zum Volltext

Verfügbarkeit prüfen

Novel Envelope Determinants for CCR3 Use by Human Immunodeficiency Virus

Journal of Virology, 2006-11, Vol.80 (21), p.10884-10889

2006

Link zum Volltext

Verfügbarkeit prüfen

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19

Frontiers in immunology, 2022-01, Vol.12, p.813300-813300

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(100)

Publikationsform

Artikel
(109)

Sprache

Englisch
(109)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Humans
(85)
Life Sciences & Biomedicine
(74)
Virology
(47)
Immunology
(26)
Hiv-1 - Physiology
(25)
Microbiology
(25)
Biological And Medical Sciences
(24)
Human Immunodeficiency Virus 1
(24)
Infectious Diseases
(23)
Animals
(22)
Hiv
(20)
Cell Line
(19)
Covid-19
(19)
Infections
(19)
Viral Diseases
(19)
Fundamental And Applied Biological Sciences. Psychology
(17)
Hiv-1 - Immunology
(17)
Human Immunodeficiency Virus
(17)
Antibodies
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

A whole genome screen for HIV restriction factors

Interferon-alpha mediates restriction of human immunodeficiency virus type-1 replication in primary human macrophages at an early stage of replication

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity

RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction

The Promiscuous CC Chemokine Receptor D6 Is a Functional Coreceptor for Primary Isolates of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 on Astrocytes

The evolution of structured illumination microscopy in studies of HIV

HIV-1 receptors and cell tropism

Curbside particulate matter and susceptibility to SARS–CoV-2 infection

Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection

The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV

Lv2, a Novel Postentry Restriction, Is Mediated by both Capsid and Envelope

HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation

Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants

An Envelope-Determined, pH-Independent Endocytic Route of Viral Entry Determines the Susceptibility of Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2 to Lv2 Restriction

CXCR4 as a Functional Coreceptor for Human Immunodeficiency Virus Type 1 Infection of Primary Macrophages

Generation of Novel Severe Acute Respiratory Syndrome Coronavirus 2 Variants on the B.1.1.7 Lineage in 3 Patients With Advanced Human Immunodeficiency Virus-1 Disease

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals

Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial

Primary Human Immunodeficiency Virus Type 2 (HIV-2) Isolates Infect CD4-Negative Cells via CCR5 and CXCR4: Comparison with HIV-1 and Simian Immunodeficiency Virus and Relevance to Cell Tropism In Vivo

Novel Envelope Determinants for CCR3 Use by Human Immunodeficiency Virus

The β-NGF/TrkA Signalling Pathway Is Associated With the Production of Anti-Nucleoprotein IgG in Convalescent COVID-19

Suchergebnisse filtern